Clinical Trial

Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels

Completed
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the hypolipidemic effect (reduction of Low Density Lipoprotein Cholesterol "LDL-C" values) of calcium-bicarbonate mineral water "Lete" (alkaline water, high in bicarbonate and calcium ions and low in sodium) compared to control oligomineral water "Sorgesana" on healthy volunteers
Protocol Amendment History 3 changes
critical Trial completed 2026-05-12
notable Primary completion pushed: 2026-03 -> 2026-04-03 2026-05-12
minor Completion pushed: 2026-03 -> 2026-04-03 2026-05-12
Trial Details
NCT Number NCT07026266
Lead Sponsor Società Generale delle Acque Minerali S.p.A.
Conditions Hypercholesterolemia
Enrollment 160 participants
Start Date 2025-09-17
Primary Completion 2026-04-03 (estimated)
Study Completion 2026-04-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-11